subperiosteal implants
Use of Subperiosteal Implants with a Unique Composite Coating: A Case Report
- 19 April 1993
- Posted by: anjaform
- Category: Clinical Studies and Case Reports
M. H. McMillan, V. Sahay, H. Hahn
Full text link: https://pubmed.ncbi.nlm.nih.gov/8007028/
Use of Subperiosteal Implants with a Unique Composite Coating: A Case Report
1. Scientific Reference
- Study title: Use of subperiosteal implants with a unique composite coating: a case report
- Authors: M. H. McMillan, V. Sahay, H. Hahn
- Scientific journal: Not specified in the information provided.
- Year of publication: Not specified in the information provided.
- PMID: 8007028
- DOI: Not specified in the information provided.
2. Scientific Context
This publication focuses on the clinical tissue response associated with a subperiosteal implant featuring a specific composite coating. The central scientific interest lies in the relationship between the implant structure and the surrounding bone, particularly the biological response observed after placement.
The case is noteworthy because the authors report bone formation extending over the subperiosteal implant. This observation raises questions regarding the interaction between the coated implant surface and the adjacent osseous environment.
However, the available abstract is extremely concise. It does not describe the clinical indication for treatment, the patient’s anatomical condition, the rationale for selecting a subperiosteal implant, or the characteristics of the composite materials. Consequently, the study should be interpreted primarily as a clinical observation rather than as evidence establishing the broader effectiveness of this implant design.
3. Study Objective
The investigators sought to evaluate the clinical response associated with a unilateral subperiosteal implant incorporating a double composite coating.
The available abstract identifies this clinical response as the primary focus of the report. No secondary objectives are described, and the information provided does not support the identification of additional clinical, prosthetic, radiographic, or biological endpoints.
4. Methodology
The publication is explicitly identified as a case report. The clinical assessment involved a unilateral subperiosteal implant characterized by a double composite coating.
Beyond these elements, methodological information is limited. The available abstract does not describe the patient’s clinical characteristics, the anatomical site involved, the surgical protocol, the composition or properties of the coating, or the method used to assess the bone response.
The duration of follow-up is not specified. Likewise, no quantitative measurement protocol, imaging assessment, histological analysis, or other evaluation method is described in the information provided.
These omissions substantially restrict the methodological interpretation of the reported observation.
5. Main Results
The principal finding concerns the bone response around the subperiosteal implant. The authors observed rapid bone growth extending over the implant structure.
This is the only clinical outcome explicitly reported in the available abstract. No quantitative measurements are provided to characterize the extent or progression of the bone formation. The information supplied also does not establish how this response was assessed or how it evolved over time.
No data are available regarding implant survival, prosthetic outcomes, biological or mechanical complications, patient symptoms, functional performance, or long-term stability.
Accordingly, the finding should be interpreted as an observation documented in an individual case rather than as evidence demonstrating the general clinical effectiveness of the implant or its composite coating.
6. Clinical Analysis
The primary clinical interest of this case report lies in the osseous response observed around a subperiosteal implant with a double composite coating. Bone formation extending over the implant structure represents a potentially relevant biological observation in the study of interactions between implant surfaces and surrounding bone.
Nevertheless, the reported finding does not establish that the composite coating itself caused or enhanced the bone response. The available information includes no comparison with an uncoated implant or with another surface configuration. It is therefore not possible to isolate the contribution of the coating to the observed biological response.
The abstract also provides no evidence that bone growth translated into improved implant stability, prosthetic function, reduced complications, or greater long-term clinical performance.
From an implant dentistry and oral surgery perspective, this report is therefore best regarded as an exploratory clinical observation. It highlights a particular tissue response associated with a specific subperiosteal implant configuration but does not provide sufficient evidence to support broader therapeutic recommendations.
Any extrapolation to other patients, implant designs, surgical indications, or rehabilitation protocols would extend beyond the information available in this report.
7. Clinical Applications
The findings are directly relevant to the study of subperiosteal implants and the biological interaction between implant structures and surrounding bone. They may therefore be of scientific interest to clinicians and researchers investigating implant surface characteristics and bone–implant relationships.
However, the abstract does not specify the clinical indication that led to the use of the subperiosteal implant. It would consequently be inappropriate to attribute specific applications to severe bone atrophy, complete edentulism, avoidance of bone grafting, or other complex implant rehabilitation scenarios on the basis of the information provided.
Similarly, no conclusions can be drawn regarding patient selection, surgical protocols, prosthetic rehabilitation, or long-term clinical indications.
8. Level of Evidence, Limitations, and Transparency
This publication is a case report and therefore provides a limited level of clinical evidence. An individual clinical observation can identify a potentially relevant biological phenomenon and contribute to hypothesis generation, but it cannot independently establish treatment efficacy or superiority.
Important methodological information is absent from the available abstract, including follow-up duration, detailed patient characteristics, the method used to assess bone growth, quantitative outcomes, and long-term clinical evolution.
No control or comparison group is mentioned. A causal relationship between the double composite coating and the observed bone response therefore cannot be established from the information provided.
Conflicts of interest or relationships with implant manufacturers: Not specified in the information provided.
9. Key Study Points
- Study type: Case report.
- Level of evidence: Limited, based on an individual case report.
- Population or number of studies analyzed: Not applicable; the publication is identified as a case report.
- Number of patients or implants: Exact number of patients not specified; the study objective refers to a unilateral subperiosteal implant.
- Follow-up duration: Not specified in the information provided.
- Primary endpoint: Clinical response associated with a double-composite-coated subperiosteal implant.
- Main finding: Rapid bone growth was observed over the subperiosteal implant.
- Scientific conclusion: The case documents an osseous response around the investigated implant configuration, but the observation cannot be generalized from the available evidence.
- Main limitations: Case-report design, limited methodological information in the available abstract, absence of quantitative data and unspecified follow-up; no comparator is mentioned.
10. Scientific Impact
The scientific contribution of this publication lies primarily in documenting an osseous response associated with a specifically coated subperiosteal implant. As a case-based observation, it provides a potential starting point for investigating how implant design and surface characteristics may interact with the surrounding bone environment.
Its scientific scope, however, remains limited by the nature and quantity of the available evidence. The report does not demonstrate a causal relationship between the double composite coating and the observed bone growth, nor does it establish a long-term clinical benefit.
The study is therefore more appropriately viewed as hypothesis-generating than practice-changing. Its value lies in recording a potentially relevant biological phenomenon that could justify further investigation under more rigorous methodological conditions. Additional evidence would be required to determine whether the observed response is reproducible and clinically meaningful.
11. Editorial Conclusion
This case report documents rapid bone growth over a subperiosteal implant incorporating a double composite coating. The observation is of interest for understanding the biological interface between subperiosteal implant structures and surrounding bone. However, the limited information available and the inherently low level of evidence of a single case require cautious interpretation. The publication should be regarded as an exploratory clinical observation rather than as validation of the coating’s effectiveness or of the implant technique itself.
